Osimert 80 mg (Osimertinib) is a targeted therapy for non-small cell lung cancer (NSCLC) with EGFR mutations. It helps slow cancer progression and improve survival. Use under medical supervision. https://iebpharma.com/product/osimert-80mg-osimertinib